Search Results - "AlMuhizi, Faisal"
-
1
Premedication Protocols to Prevent Hypersensitivity Reactions to Chemotherapy: a Literature Review
Published in Clinical reviews in allergy & immunology (01-06-2022)“…Hypersensitivity reactions (HSRs) to chemotherapy may prevent patients from receiving the most effective therapy. This review was undertaken to identify…”
Get full text
Journal Article -
2
Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
Published in Frontiers in allergy (02-02-2022)“…Coronavirus disease 2109 (COVID-19) vaccines have recently been approved to curb the global pandemic. The risk of allergic reactions to the vaccine…”
Get full text
Journal Article -
3
Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization
Published in Frontiers in allergy (03-05-2023)Get full text
Journal Article -
4
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study
Published in Annals of allergy, asthma, & immunology (01-08-2022)Get full text
Journal Article -
5
Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency
Published in Journal of allergy and clinical immunology (01-08-2019)“…The tumor TNF receptor family member 4-1BB (CD137) is encoded by TNFRSF9 and expressed on activated T cells. 4-1BB provides a costimulatory signal that…”
Get full text
Journal Article -
6
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience
Published in Annals of allergy, asthma, & immunology (01-08-2022)“…Messenger RNA coronavirus disease 2019 (COVID-19) vaccines have been associated with allergic reactions. A history of anaphylaxis has been suggested as a risk…”
Get full text
Journal Article -
7
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-02-2022)“…Clinical Implications Allergists may offer supervised mRNA coronavirus disease 2019 (COVID-19) vaccination to polyethylene glycol–allergic patients…”
Get full text
Journal Article -
8
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
Published in Journal of allergy and clinical immunology (01-08-2023)“…This guidance updates 2021 GRADE (Grading of Recommendations Assessment, Development and Evaluation) recommendations regarding immediate allergic reactions…”
Get full text
Journal Article -
9
Updated Guidance Regarding The Risk ofAllergic Reactions to COVID-19 Vaccines and Recommended Evaluation and Management: A GRADE Assessment, and International Consensus Approach
Published in Journal of allergy and clinical immunology (07-06-2023)“…This guidance updates 2021 GRADE recomendations regarding immediate allergic reactions following COVID-19 vaccines and addresses re-vaccinating individuals…”
Get full text
Journal Article -
10
-
11
Tolerance of the mRNA COVID-19 vaccines in patients with reported taxane reactions
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-08-2022)“…The U.S. Centers for Disease Control and Prevention initially recommended that patients with a history of anaphylaxis to the COVID-19 vaccine components should…”
Get full text
Journal Article -
12
Immunodeficiency and Epstein Barr virus induced lymphoproliferation caused by 4-1BB deficiency
Published in Journal of allergy and clinical immunology (11-03-2019)“…We have identified a novel immunodeficiency associated with EBV induced lymphoproliferation due to a homozygous missense mutation in 4-1BB, demonstrating a…”
Get full text
Journal Article -
13
Reply to "Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines"
Published in The journal of allergy and clinical immunology in practice (Cambridge, MA) (01-07-2022)“…Since the publication of the case series, we evaluated 2 other patients with a positive SPT to PEG 3350 (Table I). [...]given the high benefits of COVID-19…”
Get full text
Journal Article